首页> 外文期刊>Journal of Drug Delivery >Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives
【24h】

Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives

机译:使用抗坏血酸衍生物的药物纳米颗粒制剂

获取原文
       

摘要

Drug nanoparticle formulation using ascorbic acid derivatives and its therapeutic uses have recently been introduced. Hydrophilic ascorbic acid derivatives such as ascorbyl glycoside have been used not only as antioxidants but also as food and pharmaceutical excipients. In addition to drug solubilization, drug nanoparticle formation was observed using ascorbyl glycoside. Hydrophobic ascorbic acid derivatives such as ascorbyl mono- and di-n-alkyl fatty acid derivatives are used either as drugs or carrier components. Ascorbyl n-alkyl fatty acid derivatives have been formulated as antioxidants or anticancer drugs for nanoparticle formulations such as micelles, microemulsions, and liposomes. ASC-P vesicles called aspasomes are submicron-sized particles that can encapsulate hydrophilic drugs. Several transdermal and injectable formulations of ascorbyl n-alkyl fatty acid derivatives were used, including ascorbyl palmitate.
机译:最近已经引入了使用抗坏血酸衍生物的药物纳米颗粒制剂及其治疗用途。亲水抗坏血酸衍生物,例如抗坏血酸糖苷不仅已被用作抗氧化剂,而且还被用作食品和药物赋形剂。除了药物溶解以外,还使用抗坏血酸糖苷观察到药物纳米颗粒的形成。疏水抗坏血酸衍生物,例如抗坏血酸单-和二-正烷基脂肪酸衍生物,被用作药物或载体组分。抗坏血酸正烷基脂肪酸衍生物已被配制成抗氧化剂或抗癌药物,用于纳米颗粒制剂,如胶束,微乳剂和脂质体。 ASC-P囊泡称为阿斯巴素(aspasome),是可以封装亲水性药物的亚微米级颗粒。使用了抗坏血酸基正烷基脂肪酸衍生物的几种透皮和可注射制剂,包括抗坏血酸棕榈酸酯。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号